<p>A 79-year-old man, with a history of penicillin allergy, hypertension, diabetes mellitus, and multiple vertebral fractures secondary to severe osteoporosis, developed a pruritic, erythematous reaction limited to the site of application of transdermal buprenorphine.</p> <p>He had been applying transdermal buprenorphine patches for several weeks for chronic back pain before the lesions developed. After withdrawal of the transdermal buprenorphine and the use of topical high-potency corticosteroids, the lesions resolved. Skin patch tests with transdermal buprenorphine showed a papular erythematous reaction, suggesting a delayed hypersensitivity reaction.</p>
History
Publication title
Australian Pharmacist
Volume
33
Issue
9
Pagination
33-34
ISSN
0728-4632
Department/School
School of Pharmacy and Pharmacology
Publisher
Pharmaceutical Society of Australia
Place of publication
Deakin West, ACT.
Rights statement
Copyright 2014 Pharmaceutical Society of Australia